The global cardiac rhythm management (CRM) devices market size is projected to reach USD 32.4 billion by 2025. The CRM devices market is subject to witness substantial growth due to numerous awareness programs and schemes by regional governments in emerging and developed economies. The growing occurrence of cardiovascular diseases (CVDs), supportive legislative policies, and critical advancements in technology are attributed to the progress of the market in the forecast period. Though, the initial costs associated with the implementation of cardiac rhythm management (CRM) devices and lack of awareness in rural parts across the globe are limiting the market expansion of the cardiac rhythm management (CRM) devices market. The CRM devices market is expected to grow at a 7.5% CAGR during the forecast period.
Cardiac rhythm management (CRM) devices are considered the most viable option for the treatment of patients suffering from diseases like arrhythmias. The recent advancement in cardiac resynchronization therapies (CRTs) and devices are driving the market growth. Alongside, the rising use of the implantable cardioverter-defibrillators (ICDs) and its applications alongside their integration with pacemakers to improve the product’s life cycle are playing a crucial part in the treatment of heart diseases. The progress of the cardiac rhythm management (CRM) devices industry is also attributed to the factors such as the need for external defibrillators due to growing awareness of its use and the increasing occurrence of diseases related to sudden cardiac arrest (SCA).
Cardiac rhythm management (CRM) is a procedure that involves the treatment of arrhythmias (heart rhythm disorders). Arrhythmias are responsible for causing several problems for patients, such as palpitations, anxiety, and dizziness, which may lead to blackouts and cardiac arrest as well. The cardiac rhythm management (CRM) term is loosely based on treatments involving implanted electronic devices similar to pacemakers and defibrillators. Cardiac rhythm management (CRM) devices are mainly classified into three common types such as pacemakers, implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT). Pacemakers are used for the treatment of slow heart rates or attacks in a dire situation where the heart stops functioning, leading to dizziness, blackouts, or even death. They provide a small number of electrical impulses that may trigger the heartbeat.
The other type of cardiac rhythm management (CRM) device such as implantable cardioverter-defibrillator (ICD) is implemented in case of sudden cardiac arrests because of the faster or chaotic beating in the central pumping chamber i.e. ventricular tachycardia. In such scenarios, an implantable cardioverter-defibrillator (ICD) creates a shockwave to restore the normal heart rhythm, the shock is created automatically within seconds. The use of cardiac resynchronization therapy (CRT) devices allows the proper functioning of poorly coordinated ventricles such as central pumping chambers that can lead to heart failure. CRT devices are responsible for pacing the left ventricle involving a central pumping chamber from both sides of the ventricles. This provides relaxation for patients from symptoms and boosts their morality.
The use of ICDs and CRT devices offers an immediate and long-term solution in comparison with the bradycardia pacemakers. Implanting both CRT and ICD devices on patients is vital for successful treatment. The applications of these devices aids to amplify the health outcomes and ensuring welfare for patients by designing devices to carry out the highly efficient therapy, at times evaluating and reducing system complications while utilizing precise device diagnostic data for successful treatment.
The market is divided into regional market segments such as North America, Europe, Asia-Pacific, Latin America, and Africa. North America has shown major growth in recent years owing to the rise adoption of the latest technologies in the healthcare sector and the existence of well-established healthcare infrastructure. The asia-Pacific market is predicted to hold a higher share in the cardiac rhythm management (CRM) devices market with massive growth in the forecast period.
Countries such as India, China, and Singapore are leading the Asia-Pacific market with growing penetration of health insurance in emerging economies and generating substantial investment by multinational market players due to potential opportunities in the region. The key players in the cardiac rhythm management (CRM) devices industry are Medtronic Ltd., BIOTRONIK Incorporations, Boston Scientific Co., St. Jude Medical Co., ZOLL Medical Co., and Philips N.V.
CRM devises Product Outlook (Revenue, USD Million, 2014 - 2025)
• Implantable Pacemakers
• External Pacemakers
• Implantable Cardioverter Defibrillators (ICDs)
• Subcutaneous ICD (S-ICD)
• Transvenous ICD (T-ICD)
• External Defibrillator (ED)
• Manual ED
• Automated ED (AED)
• Wearable Cardioverter Defibrillator
• Cardiac Resynchronization Therapy (CRT)
• CRT-Defibrillators (CRT-D)
• CRT-Pacemakers (CRT-P)
CRM devises Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• the U.S.
• the U.K.
• the Asia Pacific
• Latin America
• the Middle East and Africa (MEA)
• South Africa
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...